Showing results (1121-1130 of 1,155) with videos related to

Sort By:
Pageof 116
Nature Communications|August 4, 2022
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spikeMathieu Claireaux, Tom G Caniels, Marlon de Gast, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Identification of a broad and potent V3 glycan site bNAb targeting an N332gp120 glycan-independent epitopeLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2024
Evolution of clinical nature, treatment and survival of locally recurrent rectal cancer: Comparative analysis of two national cross-sectional cohortsE G M van Geffen, J M A Langhout, S J A Hazen, et al.
Langenbeck'S Archives of Surgery|March 26, 2016
Characteristics of contralateral carcinomas in patients with differentiated thyroid cancer larger than 1 cmLutske Lodewijk, Wouter P Kluijfhout, Jakob W Kist, et al.
Cell Reports. Medicine|April 12, 2023
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertionsTom G Caniels, Max Medina-Ramírez, Jinsong Zhang, et al.
Cell Metabolism|July 31, 2024
Single-nucleus transcriptomics identifies separate classes of UCP1 and futile cycle adipocytesTongtong Wang, Anand Kumar Sharma, Chunyan Wu, et al.
Science (New York, N.Y.)|June 20, 2015
HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimersRogier W Sanders, Marit J van Gils, Ronald Derking, et al.
Nature Genetics|August 4, 2022
Molecular map of chronic lymphocytic leukemia and its impact on outcomeBinyamin A Knisbacher, Ziao Lin, Cynthia K Hahn, et al.
Nature Communications|May 21, 2016
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibitionJan A Burger, Dan A Landau, Amaro Taylor-Weiner, et al.
The Lancet. Haematology|September 8, 2020
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trialCourtney D DiNardo, Abhishek Maiti, Caitlin R Rausch, et al.
Pageof 116